|
Market Closed -
Hong Kong S.E.
04:08:03 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.8500 HKD | 0.00% |
|
-0.58% | -20.56% |
| 09-01 | Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit | MT |
| 08-25 | Regent Pacific Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 31.63M 248M 27.22M 25.61M 23.4M 43.77M 2.99B 43.88M 303M 117M 1.53B 119M 116M 4.94B | P/E 2024 |
-2.39x | P/E 2025 | -7.63x |
|---|---|---|---|---|---|
| Enterprise Value | 35.42M 278M 30.48M 28.67M 26.19M 49M 3.34B 49.13M 339M 131M 1.72B 133M 130M 5.53B | EV / Sales 2024 |
19.4x | EV / Sales 2025 | 121x |
| Free-Float |
31.54% | Yield 2024 * |
-
| Yield 2025 | - |
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 575 | Delayed | |
Deutsche Boerse AG
| RPG | Delayed | |
|
Börse Stuttgart
| RPG | Delayed |
| 1 week | -0.58% | ||
| Current month | +0.59% | ||
| 1 month | -11.92% | ||
| 3 months | +39.34% | ||
| 6 months | -5.56% | ||
| Current year | -20.56% |
| 1 week | 0.82 |  | 0.94 |
| 1 month | 0.82 | | 0.97 |
| Current year | 0.57 | | 1.22 |
| 1 year | 0.57 | | 1.22 |
| 3 years | 0.32 | | 1.24 |
| 5 years | 0.25 | | 4.06 |
| 10 years | 0.25 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 60 | 2002-04-30 |
Yui Fui Wong
DFI | Director of Finance/CFO | 51 | 2010-12-31 |
Michael Wyllie
CTO | Chief Tech/Sci/R&D Officer | 75 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jim Mellon
CHM | Chairman | 70 | 1993-12-31 |
Jamie Gibson
BRD | Director/Board Member | 60 | 2001-12-31 |
Stawell Searle
BRD | Director/Board Member | 82 | 2001-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/5/23 | Other | Director | 3,639,574 | 0.1517% | ||
| 6/5/23 | Other | Founder | 2,455,657,694 | - | ||
| 6/5/23 | Other | Chief Executive Officer | 149,249,568 | 6.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.58% | +6.25% | -18.27% | 31.63M | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| Average | -0.89% | +0.93% | +26.09% | +44.19% | 367.84B | |
| Weighted average by Cap. | -1.10% | +0.55% | +36.62% | +66.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 719K 5.64M 619K 582K 532K 995K 67.88M 997K 6.88M 2.67M 34.83M 2.7M 2.64M 112M | 363K 2.85M 312K 294K 268K 502K 34.27M 504K 3.47M 1.35M 17.58M 1.36M 1.33M 56.65M |
| Net income | -4.48M -35.14M -3.86M -3.63M -3.31M -6.2M -423M -6.22M -42.88M -16.64M -217M -16.83M -16.46M -699M | -4.71M -36.93M -4.05M -3.81M -3.48M -6.52M -445M -6.53M -45.06M -17.49M -228M -17.69M -17.3M -735M |
| Net Debt | 3.22M 25.23M 2.77M 2.6M 2.38M 4.45M 304M 4.46M 30.78M 11.94M 156M 12.08M 11.82M 502M | 3.78M 29.66M 3.26M 3.06M 2.8M 5.23M 357M 5.25M 36.19M 14.04M 183M 14.21M 13.9M 590M |
Employees
15
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | HK$0.8500 | 0.00% | 0 |
| 26-09-03 | HK$0.8500 | 0.00% | 20,000 |
| 26-09-02 | HK$0.8500 | +0.59% | 40,050 |
| 26-09-01 | HK$0.8450 | 0.00% | 0 |
| 26-08-31 | HK$0.8450 | -1.17% | 132,500 |
- Stock Market
- Stocks
- 575 Stock
Select your edition
All financial news and data tailored to specific country editions
